Troy Edward Wilson
President and CEO at Kura Oncology Inc.
Sits on 3 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Kura Oncology Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Puma Biotechnology Inc | Open-market sale | โ5,000 | $9.10 | $45,500 |
| Aug 24, 2026 | Kura Oncology Inc. | Open-market purchase | +100,000 | $12.39 | $1,239,000 |
| Aug 17, 2026 | Kura Oncology Inc. | Open-market purchase | +100,000 | $11.12 | $1,112,000 |
| Jun 12, 2026 | Puma Biotechnology Inc | Open-market sale | โ10,800 | $7.20 | $77,760 |
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | โ | โ |
| Mar 23, 2026 | Kura Oncology Inc. | Option exercise | +6,103 | $6.15 | $37,533 |
| Nov 13, 2025 | Kura Oncology Inc. | Grant or award | +182,500 | โ | โ |
| Sep 29, 2025 | Kura Oncology Inc. | Open-market sale | โ36,615 | $8.94 | $327,338 |
| Sep 27, 2025 | Kura Oncology Inc. | Grant or award | +182,500 | โ | โ |
| Sep 8, 2025 | Kura Oncology Inc. | Open-market purchase | +50,000 | $8.20 | $410,000 |
| Aug 13, 2025 | Kura Oncology Inc. | Open-market purchase | +13,494 | $6.64 | $89,600 |
| Aug 12, 2025 | Kura Oncology Inc. | Open-market purchase | +36,506 | $5.85 | $213,560 |
| Jun 13, 2025 | Puma Biotechnology Inc | Open-market sale | โ10,800 | $3.40 | $36,720 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | โ | โ |
| Jun 18, 2024 | Puma Biotechnology Inc | Grant or award | +27,000 | โ | โ |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.